Orchid Pharma, a leading pharmaceutical company, has secured a major milestone with the approval of its innovative antibiotic by the Drugs Controller General of India (DCGI). This approval paves the way for the manufacturing and marketing of Enmetazobactam, a New Chemical Entity Active Pharmaceutical Ingredient (API) discovered and developed entirely within India. About Enmetazobactam The …


